Investigating the therapeutic efficacy of psilocybin in advanced cancer patients: A comprehensive review and meta-analysis

Excerpts from the publication

Background: Psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, is known for its effects on anxiety and depression. It has recently gained increasing interest for its potential therapeutic effects, particularly in patients with advanced cancer. This systematic review and meta-analysis aim to evaluate the effects of psilocybin on adult patients with advanced cancer.

The acute effects of classic psychedelics on memory in humans

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955 – 2021)

Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants